A detailed history of Ever Source Wealth Advisors, LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 2,270 shares of HALO stock, worth $103,625. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,270
Previous 2,381 4.66%
Holding current value
$103,625
Previous $124,000 4.03%
% of portfolio
0.01%
Previous 0.01%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$51.3 - $64.42 $5,694 - $7,150
-111 Reduced 4.66%
2,270 $129,000
Q2 2024

Aug 13, 2024

BUY
$37.81 - $52.4 $1,550 - $2,148
41 Added 1.75%
2,381 $124,000
Q1 2024

Jun 11, 2024

SELL
$33.68 - $41.95 $2,256 - $2,810
-67 Reduced 2.78%
2,340 $95,000
Q4 2023

Feb 09, 2024

SELL
$33.32 - $42.1 $2,732 - $3,452
-82 Reduced 3.29%
2,407 $88,000
Q3 2023

Nov 03, 2023

BUY
$36.46 - $44.03 $1,458 - $1,761
40 Added 1.63%
2,489 $95,000
Q2 2023

Aug 04, 2023

BUY
$30.28 - $38.74 $74,155 - $94,874
2,449 New
2,449 $88,000
Q2 2022

Aug 01, 2022

SELL
$37.35 - $48.3 $8,030 - $10,384
-215 Closed
0 $0
Q4 2021

Feb 07, 2022

BUY
$31.82 - $40.75 $6,841 - $8,761
215 New
215 $9,000

Others Institutions Holding HALO

About HALOZYME THERAPEUTICS, INC.


  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $6.36B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Ever Source Wealth Advisors, LLC Portfolio

Follow Ever Source Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ever Source Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ever Source Wealth Advisors, LLC with notifications on news.